Adjustable continence balloons in postprostatectomy incontinence: Outcomes and complications.
adjustability
balloons
prostatectomy
satisfaction
stress urinary incontinence
Journal
Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
02
05
2022
received:
01
02
2022
accepted:
18
05
2022
pubmed:
11
6
2022
medline:
28
7
2022
entrez:
10
6
2022
Statut:
ppublish
Résumé
The objective of this study was to assess the mid-term efficacy and safety of adjustable continence therapy (ProACT™) for the treatment of male stress urinary incontinence (SUI) after radical prostatectomy (RP). Single-center retrospective study including male patients implanted with ProACT™ periurethral balloons for SUI after RP between 2007 and 2017, mainly with flexible cystoscopic guidance. Efficacy was assessed using a composite endpoint with subjective (patient's impression of improvement (PII), using a 0-100 numeral rating scale) and objective outcomes (decrease in daily pad use). Postoperative success was defined as a PII ≥ 80%, associated with the use of 0-1 pad daily. Improvement was defined as a PII ≥ 50% and a decrease ≥50% in the number of daily pads used. Two hundred men with a median age of 68 (64-73) years were included. Seventeen percent (n = 34) had had prior radiotherapy and 15.5% (n = 31) had had prior SUI surgery. The median follow-up was 43 (19-71) months. The severity of SUI was as follows: mild in 119 (59.5%), moderate in 48 (24%), and severe in 33 patients (16.5%). Severe SUI and a history of prior radiotherapy were associated with a lower success rate (p = 0.033 and p < 0.0001). The overall reoperation rate was 34%, with 5.6% (n = 11) requiring a third implantation. Of the patients, 29.4% (n = 58) required an artificial urinary sphincter to treat SUI. At the last follow up, among the overall population, the success rate was 40.1% and the median PII was 18.3%. For patients in whom the balloons were still in place (n = 132), the cumulative success and improvement rate was 78%, with a median PII of 72%. The minimally invasive ProACT™ device provides a clear beneficial continence outcome in patients with SUI after radical prostatectomy. Severe SUI or prior radiotherapy were associated with a lower success rate in our study.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1414-1422Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Crivellaro S, Morlacco A, Bodo G, et al. Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence. Neurourol Urodyn. 2016;35(8):875-881. doi:10.1002/nau.22873
Dubbelman YD, Groen J, Wildhagen MF, Rikken B, Bosch JLHR. Urodynamic quantification of decrease in sphincter function after radical prostatectomy: relation to postoperative continence status and the effect of intensive pelvic floor muscle exercises. Neurourol Urodyn. 2012;31(5):646-651. doi:10.1002/nau.21243
Ficazzola MA, Nitti VW. The etiology of post-radical prostatectomy incontinence and correlation of symptoms with urodynamic findings. J Urol. 1998;160(4):1317-1320. doi:10.1016/S0022-5347(01)62525-4
Bauer RM, Gozzi C, Hübner W, et al. Contemporary management of postprostatectomy incontinence. Eur Urol. 2011;59(6):985-996. doi:10.1016/j.eururo.2011.03.020
Tutolo M, Cornu JN, Bauer RM, et al. Efficacy and safety of artificial urinary sphincter (AUS): results of a large multi-institutional cohort of patients with mid-term follow-up. Neurourol Urodyn. 2019;38(2):710-718. doi:10.1002/nau.23901
Aa F, Drake M, Kasyan G, Petrolekas A, Cornu JN. The Artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol. 2012;63:63-69. doi:10.1016/j.eururo.2012.11.034
Bauer RM, Bastian PJ, Gozzi C, Stief CG. Postprostatectomy incontinence: all about diagnosis and management. Eur Urol. 2009;55(2):322-333. doi:10.1016/j.eururo.2008.10.029
Hübner WA, Schlarp OM. Adjustable Continence Therapy (ProACT™): evolution of the surgical technique and comparison of the original 50 patients with the most recent 50 patients at a single centre. Eur Urol. 2007;52(3):680-686. doi:10.1016/j.eururo.2006.10.054
Gravas S, Cornu JN, Gacci M, Gratzke C, Herrmann T, Mamoulakis C. Management of Non-neurogenic Male LUTS- Uroweb. European Association of Urology; 2022. https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/summary-of-changes
Luyckx F, Vayleux B, Poitrineau C, et al. Evaluation of the medium-term results of treatment of male urinary incontinence due to sphincteral insufficiency, with periurethral balloons (Pro-ACT). Monocentric study on 60 consecutive patients. Pelvi-Périnéologie. 2010;5(1):2-8. doi:10.1007/s11608-010-0291-4
Chartier-Kastler E, Bart S, Mozer P. Ballons ACT™/Pro-ACT™ (Medtronic, Etats-Unis): technique et indications. Prog En Urol. 2009;19(2):F48-F52. doi:10.1016/j.fpurol.2008.08.001
Le Normand L. ACT periurethral adjustable balloons for treating female stress urinary incontinence. Pelvi-Périnéologie. 2007;2(2):198-202. doi:10.1007/s11608-007-0122-4
Gregori A, Romanò AL, Scieri F, et al. Transrectal ultrasound-guided implantation of adjustable continence therapy (ProACT): surgical technique and clinical results after a mean follow-up of 2 years. Eur Urol. 2010;57(3):430-436. doi:10.1016/j.eururo.2009.11.031
Rouprêt M, Misraï V, Gosseine PN, Bart S, Cour F, Chartier-Kastler E. Management of stress urinary incontinence following prostate surgery with minimally invasive adjustable continence balloon implants: functional results from a single center prospective study. J Urol. 2011;186(1):198-203. doi:10.1016/j.juro.2011.03.016
Mitropoulos D, Artibani W, Graefen M, Remzi M, Rouprêt M, Truss M. Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Eur Urol. 2012;61(2):341-349. doi:10.1016/j.eururo.2011.10.033
Finazzi Agrò E, Gregori A, Bianchi D, et al. Efficacy and safety of adjustable balloons (Proact™) to treat male stress urinary incontinence after prostate surgery: medium and long-term follow-up data of a national multicentric retrospective study. Neurourol Urodyn. 2019;38(7):1979-1984. doi:10.1002/nau.24103
Vayleux B, Luyckx F, Thélu S, et al. Adjustable continence therapy in women, middle term follow-up and a new technique for balloon positioning. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. 2010;20(7):520-526. doi:10.1016/j.purol.2010.01.010
Kocjancic E, Crivellaro S, Ranzoni S, Bonvini D, Gontero P, Frea B. Adjustable continence therapy for the treatment of male stress urinary incontinence: a single-centre study. Scand J Urol Nephrol. 2007;41(4):324-328. doi:10.1080/00365590601153488
Venturino L, Dalpiaz O, Pummer K, Primus G. Adjustable continence balloons in men: adjustments do not translate into long-term continence. Urology. 2015;85(6):1448-1453. doi:10.1016/j.urology.2015.01.045
Lebret T, Cour F, Benchetrit J, et al. Treatment of postprostatectomy stress urinary incontinence using a minimally invasive adjustable continence balloon device, ProACT: results of a preliminary, multicenter, pilot study. Urology. 2008;71(2):256-260. doi:10.1016/j.urology.2007.08.062
Gilling PJ, Bell DF, Wilson LC, Westenberg AM, Reuther R, Fraundorfer MR. An adjustable continence therapy device for treating incontinence after prostatectomy: a minimum 2-year follow-up. BJU Int. 2008;102(10):1426-1431. doi:10.1111/j.1464-410X.2008.07816.x
Nestler S, Thomas C, Neisius A, et al. Long-term results of ProACT primary and repeat implantation for treatment of stress urinary incontinence in men. World J Urol. 2018;37:1173-1179. doi:10.1007/s00345-018-2483-4
Noordhoff TC, Scheepe JR, Blok BFM. Outcome and complications of adjustable continence therapy (ProACT™) after radical prostatectomy: 10 years' experience in 143 patients. Neurourol Urodyn. 2018;37(4):1419-1425. doi:10.1002/nau.23463
Kjaer L, Fode M, Nørgaard N, Sønksen J, Nordling J. Adjustable continence balloons: clinical results of a new minimally invasive treatment for male urinary incontinence. Scand J Urol Nephrol. 2012;46(3):196-200. doi:10.3109/00365599.2012.660986
Nash S, Aboseif S, Gilling P, et al. Four-year follow-up on 68 patients with a new post-operatively adjustable long-term implant for post-prostatectomy stress incontinence: ProACT™. Neurourol Urodyn. 2018;38:248-253. doi:10.1002/nau.23838